BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Metaproterenol

A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.

298+ PubMed studies analyzed · 71 RCTs · Evidence Score: 52.3

Research Domains

Metaproterenol has been studied across 20 research domains including 🫁 Respiratory, ❤️ Cardiovascular, 😴 Sleep, 🫁 Liver & Detox, 🫘 Kidney. The primary research focus is 🫁 Respiratory with 66% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Metaproterenol, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Flavin
2 shared targets
Oxprenolol
2 shared targets
Fenoterol
3 shared targets
Atenolol
2 shared targets
Ranolazine
2 shared targets
Alprenolol
2 shared targets
doxazosin
2 shared targets
Levalbuterol
2 shared targets
Levalbuterol
2 shared targets
Phenylephrine
2 shared targets
Loading evidence profile...

This evidence profile for Metaproterenol is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.